LILRB4 and Zika virus infectious disease: Their central role in controlling ZIKV infection was confirmed by the increased viral loads and reduced survival in mice treated with anti–NK1.1 antibodies and the rescue in ZIKV-infected LILRB4-KO mice that received NK cells from WT mice.